Search Index

They are on the IUCN red list as 'vulnerable' Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Conservation of marine iguanas 29/03/26, 16:01 Last updated: Published: 06/01/24, 10:40 They are on the IUCN red list as 'vulnerable' The marine iguana ( Amblyrhynchus cristatus ), also known as the sea iguana, is a unique species. It is the world’s only ocean- going lizard. Their main food source is algae; large males can dive to forage for this source, while females feed during low tide. They can be found on rocky shorelines, but also on marshes, mangrove swamps and beaches of the Galapagos. Their range is limited to the Galapagos islands, so they are an isolated species. Currently, they are on the IUCN red list as ‘vulnerable’ with a current population estimated at 200,000, and conservation efforts are needed to stabilise populations. Key threats There are three key threats to iguana populations. The first is invasive species; animals such as pigs, dogs and cats feed on young hatchlings and iguana eggs, which reduces the long-term survival rate of the species. Marine iguanas have not yet developed defence strategies against these predators. Even humans introduce pathogens to the islands that pose a threat to the species, because of their isolated habitat, the marine iguana lacks immunity to many pathogens and so has a higher risk of contracting diseases. Climate change is another key threat. El Niño is a weather event that prevents cold, nutrient-rich waters, that the marine wildlife depends on, from reaching the Eastern Tropical Pacific. This depletes algae populations, and this food drop drastically reduces iguana populations ( Figure 1 ). With global warming, El Niño events are expected to be more prominent and more frequent. It has been found that during El Niño events, marine iguanas experience metabolic stress, resulting in reduced metabolic rates. In addition, pollution from humans like oil spills and microplastics are damaging their habitat. Current and future conservation methods Under the laws of Ecuador, marine iguanas are completely protected. Their land range is in the Galapagos National Park, and their sea range is within the Galapagos Marine Reserve. They are also listed on the CITES, which ensures monitoring the trade of endangered animals to inhibit damage to their numbers. Sanctuaries are also in place to mitigate against extinction, but their specialised diet is challenging. So, what does the future hold for marine iguanas? The biggest challenge is the distribution of the species. The population is scattered across the different islands of the Galapagos as such, there are at least 11 subspecies. This brings more complications to marine iguana conservation. As these subspecies specialise, it becomes less likely they will breed, thus more difficult to maintain the species population. Introducing education and awareness programmes will better equip us to the dangers faced by marine iguanas and could be a tourism idea for the Galapagos. This species is one of a kind, which is why it is so important for them to be protected.There should be a monitoring scheme, as suggested by MacLeod and Steinfartz, 2016 ( Figure 2 ), but the location of these subspecies makes it difficult to monitor them. However, there was a recent study using drone-based methods which showed promising results ( Figure 3 ). The overarching question remains: do we continue to conserve the current population in the Galapagos, or should we relocate the species to a less endangered habitat? Written by Antonio Rodrigues Related articles: Conservation of Galapagos Tortoises / 55 years of vicuna conservation Project Gallery

Book review Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link 'Intern Blues' by Robert Marion, M.D. 08/01/26, 18:59 Last updated: Published: 01/09/24, 12:30 Book review The public's glimpse of a doctor’s life varies depending on the doctor. Popular TV shows like Grey’s Anatomy , New Amsterdam , and Private Practice allow keen viewers to follow the romanticised lives of doctors, from their heroic moments to the romances and tragedies that take place in their hospital shifts. Similarly, social media platforms have been filled with doctors and medical students glamourising their experience with hashtags and filters, focusing on the positive but hardly ever commenting on their negative experiences. Additionally, flashy news articles celebrate a doctor’s innovative and ground-breaking methods and attempts to save a lucky patient’s life. In particular, doctors were placed in the spotlight during the COVID-19 pandemic, being seen as the real-life superheroes of the pandemic. On the other hand, in 2023, the televised NHS doctors’ protests presented the struggles and hardships endured by the professionals. Furthermore, a report by the General Medical Council in 2022 found that 50% of doctors were unhappy in their workplace. Simply put, the public’s perspective towards medicine and a doctor’s life will differ depending on their source and possibly their personal experiences. Therefore, how can one understand the world through the eyes of a doctor without studying and working within the profession? This question may never have a perfect answer, but the book Intern Blues by Robert Marion could be considered a step in the right direction. This book explores the life of three first-year interns (Amy, Adam, and Mark) in New York paediatric hospitals during the mid-1980s. After meeting his new interns and learning about the fear and outsider syndrome they felt toward the coming year, Dr. Robert Marion encouraged them to document their experiences during their year as interns to reflect and possibly learn through their achievements and struggles. Unknowingly, Dr Marion’s advice created the concept behind this inspiring book. The book explains treatment methods, their reasoning, and the medical abbreviations, making any reader feel like a doctor. This is emphasised by the vividly descriptive writing and the constant log of emotions, allowing anyone to experience the vibrant rush of a hospital from the comfort of their home. One of the best things about this book is each intern’s contrasting perspectives on such supposedly similar experiences. The first intern, Andy Baron, explored his struggles of living far from his family and girlfriend due to his awkward working hours and his feelings that his loved ones do not understand what he is going through. On the other hand, Amy Horowitz has an intriguing perspective of being a mother of a young child, presenting to the reader the struggles with viewing her own child in her patients' eyes and how she surpassed this challenge to succeed in her work. In contrast, Mark Greenberg has an interesting and almost humoristic negative perspective towards his experience – one should note that, at times, some of his entries are quite shocking with their abruptness and pessimistic view. On the other hand, one of the few limitations to note in this book would be the timing. Having taken place in the 1980s, the reader should note that some elements have changed and evolved over the years. However, one could argue that this difference in 40 years gives a uniqueness to the book as it allows for a comparison and reflection on how medicine has changed. For instance, there is a brief exploration of the struggle that Amy faced as a doctor: struggles that in some way stem from how being a woman made others view her differently from her male colleagues. Although these same struggles may not apply to female doctors in the present, the Amys of 2024 encounter their own challenges. Moreover, the book provides an interesting reflection on how the HIV pandemic changed medicine and forced the medical community to adapt – which, for many readers, can resonate with the recent COVID-19 pandemic. Intern Blues is an entertaining read that will make its readers want to hug their siblings and appreciate their lives differently. This book will elicit laughs, tears, and moments of profound contemplation - a rollercoaster of emotions filled to the brim with intriguing medical cases. Presenting the hardships these three doctors faced, one has the opportunity to reflect and decide for themselves: does the good outweigh the bad? What causes the balance to tip? Is a doctor’s life made for them? Nevertheless, one conclusion is constant: the newfound admiration for the healthcare community. Check out this book on Amazon Written by Inês Couto André Related article and book reviews: Healthcare serial killers / The Emperor of All Maladies / The Molecule REFERENCES Marion R. The Intern Blues: The Timeless Classic about the Making of a Doctor. Reprint edition. William Marrow & Company; 2001. General Medical Council. The State of Medical Education and Practice in the UK, Workplace Experiences 2023 [Internet]. General Medical Council. 2023 June. Available from: gmc-uk.org/stateofmed . Project Gallery

Protective bodies regulate animal use in research worldwide Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Animal ethics: the good, the bad, and the ugly? 03/04/26, 16:04 Last updated: Published: 09/06/24, 11:07 Protective bodies regulate animal use in research worldwide Many research trials involve using animals, specifically those labelled as ‘model organisms’. This refers to species of animals that are desirable for scientific research as they are usually cost-effective, easily manipulated, and well understood in terms of their genetic background. Good knowledge of their genetic background allows for these experiments to be applied with the intention of human benefit. Protective bodies regulate animal use in research worldwide, albeit with various degrees of severity. One of the strictest regions when it comes to animal legislation is the United Kingdom. The Animal Scientific Procedures Act 1986 protects the use of animals in the UK; they, do this by only licensing trusted individuals and experiments that follow the principle of the ‘3Rs’. This principle aims to; r educe the number of animals used r efine procedures to reduce pain r eplace experiments on animals with artificial systems such as cell cultures. In November 2025, the UK government published its official roadmap to accelerate the transition away from animal use in science; "This includes an end to regulatory testing on animals to assess the potential for new treatments to cause skin and eye irritation and skin sensitisation by the end of 2026." Research by Byron Blagburn and coworkers had some controversy as they tested four commercially available heartworm preventatives in dogs, as they first had to infect them. This parasitic worm that was infected in the dogs is extremely severe and life-threatening. The point of the experiment was to see which was the most effective treatment, and they did find that the combination of imidacloprid and moxidectin was 100% effective at eradicating the infection. Despite this research being approved by the Auburn University, Alabama USA Institutional Animal Care and Use Committee, many ethical principles were breached. As the dogs had no choice but to participate in the experiment which completely disregards the autonomy of the dogs. However, Byron and his colleagues would counteract that argument by saying they acted with beneficence as the study’s intention was to find out what was the best treatment for the dogs to improve their health. But for this beneficence to be achieved, non-maleficence was broken as the dogs were given parasitic infections that inflicted pain. Unfortunately, according to the DxE investigators (Direct Action Everywhere), after 5 months the dogs were euthanised. Although the researchers defended the morality of their study by pointing out that all treatments were already in commerce, some have argued that the infection of a previously healthy dog with a parasite is morally wrong. Many religions and groups oppose the use of animals in research as they value animal life as much as human life. Buddhists, for example, believe that animals have moral significance, as the Buddha condemns occupations that involve harming animals and encourages his followers to help animals where they can. While many groups stand against this research, most of our findings and medicine today would not be available without the contribution of animals. According to the American Medical Association: Virtually every advance in medical science in the 20th century, from antibiotics and vaccines to antidepressant drugs and organ transplants, has been achieved either directly or indirectly through the use of animals in laboratory experiments. Thus, showing how important the use of animals is in terms of medical advancements and improvement of human life. One of the most vocal groups is People for the Ethical Treatment of Animals ( PETA): PETA is an organisation advocating for animal rights and strongly opposing many of the current research studies. For example, the research of sepsis is undertaken at many universities like Pittsburgh and California involves puncturing of mice intestines while awake and then stitching multiple of these punctured mice together. This then leads to the excruciating death of these animals. Now, this has aided in the knowledge of sepsis and potential treatment. However, the autonomy of the animals is disregarded whilst the researchers act with maleficence. Therefore, we are at a vital stage with animal experimentation as the intention is for improving health and can be argued to be necessary for the advancing medicine for humans and animals. Nevertheless, religious groups and animal rights groups believe that justice is not being served as the animals are subject to harm without a choice. Despite the advancements of artificial systems such as organ-on-a-chip (OOC) - multi-channel 3-D microfluidic cell culture that simulates the activities, mechanics and physiological response of an entire organ or an organ system, the findings of animal studies are required before trialling within humans. When artificial systems improve and become more available there could be a world where animal studies are limited or non-existent to please animal rights activists and still aid the enhancements of modern-day medicine. Written by Harvey Wilkes Related articles: Regulation and policy of stem cell research / Miniature organs in biomedicine REFERENCES Blagburn, B.L., Arther, R.G., Dillon, A.R., Butler, J.M., Bowles, J.V., von Simson, C. and Zolynas, R., 2016. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis. Parasites & vectors, 9, pp.1-10. Mice stitched together, injected with bacteria-take action! (no date) PETA. Available at: https://support.peta.org/page/6980/action/1?locale=en-US (Accessed: 29 May 2024). Project Gallery

Investigating the outbreak in Devon, UK in May 2024 Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Cryptosporidium: bridging local outbreaks to global health disparities 20/03/25, 12:06 Last updated: Published: 01/09/24, 12:50 Investigating the outbreak in Devon, UK in May 2024 In early May, news emerged of numerous Devon (UK) residents experiencing vomiting and diarrhoea. Majorly affecting the Brixham region, over 40 people were diagnosed with cryptosporidiosis, and over 16,000 homes were advised to boil water before consuming it to kill potential pathogens ( Figure 1 ). Despite a controversial handling of the situation from South West Water (SWW) (from initial denial of the ‘crisis’, to major profit increases for the company), the outbreak was eventually linked to a broken pipe from where animal faeces could have entered, contaminating the water supply, a SWW representative suggested. In this article, we will investigate the disease and its relevance worldwide. So, what is Cryptosporidiosis? Cryptosporidiosis is commonly associated with gastrointestinal symptoms, such as vomiting, diarrhoea and severe abdominal cramps. It is caused by cryptosporidium, from the Apicocomplexa family. This microorganism is an intra-cellular gut parasite which invades the microvilli in the gut and depletes host nutrients. The parasite is spread via faecal-oral transmission, and it is commonly found in contaminated water, food and animals. Its life cycle starts with oocyst (egg) ingestion, leading to attachment to host gut epithelia, and asexual reproduction. This allows sexual reproduction to ensue, and oocyst formation. Eventually, the oocysts are released via faeces, for the cycle of infection to continue. Cryptosporidium species are often identified by the immune system via Toll-Like Receptors, specifically TLR-4, in the gut epithelia; Cryptosporidium-derived molecules are treated as TLR-4 ligands, since the microbe does not produce LPS molecules. Adaptive immune signalling pathways, such as NF-kB, are triggered, encouraging IL-8, CXCL1 and other chemokine secretion from the gut ( Figure 2 ). Consequently, gut inflammation is increased, as well as levels of Intracellular Adhesion Molecule-1 (ICAM-1), to aid immunocyte recruitment and improve pathogenic clearance. Other mechanisms the epithelial barrier uses to eliminate cryptosporidium infection include NO secretion and mucin production, to kill the pathogen, and prevent further infection by blocking extracellular oocyst binding, respectively. In some individuals, cryptosporidium can evade immune response due to its intracellular nature. Most immunocompetent patients suffer mild symptoms and so are offered symptomatic treatment, but some immunocompromised patients (those with HIV, for example) can develop chronic diarrhoea as a result of cryptosporidium infection. In this instance, managing fluid loss and rest is often insufficient; these patients are prescribed nitazoxanide, a broad-spectrum antiparasitic, to manage their diarrhoea. Cryptosporidiosis on a global scale Although controversial, the management of the cryptosporidium ‘crisis’ in Devon was resolved relatively quickly compared to outbreaks in other countries ( Figure 3 ). There are clear links between socio-economic dynamics and water-borne illness prevalence. In some developing regions, such as areas in the Middle East and North Africa (MENA), cryptosporidiosis is considered endemic, due to poor quality water-sanitation centres, rapid population growth and inadequate potable water supply. Globally, 3.4 million people die each year from water-borne illnesses - and poor sanitation ranks higher in causes of human morbidity than war and terrorism. Additionally, in 2015, cryptosporidium was the fourth leading cause of death amongst children under 5, clearly highlighting the danger this parasite can cause. For children in developing countries, who are already predisposed to starvation, cryptosporidiosis can kick-start a malnutrition cycle. Here, cryptosporidium exacerbates host malnutrition due to its parasitic nature, potentially causing cognitive impairment and growth stunting. Cryptosporidiosis, although typically mild, can be devastating for some people (the immunocompromised and young children). Particularly, those who are malnourished can suffer severe effects. The water contamination in Devon (UK), handled by SWW, was unfortunate and many in the region experienced severe illness. Globally, cryptosporidiosis is a major problem and in some regions, it is considered endemic. Thus, it is important we spread awareness of the devastating effects of this disease, continue efforts to prevent transmission and strive for eradication. Written by Eloise Nelson REFERENCES Abuseir, S. (2023) ‘A systematic review of frequency and geographic distribution of water-borne parasites in the Middle East and North Africa’, Eastern Mediterranean Health Journal , 29(2), pp. 151–161. doi:10.26719/emhj.23.016. Chalmers, R.M., Davies, A.P. and Tyler, K. (2019) ‘Cryptosporidium’, Microbiology , 165(5), pp. 500–502. doi:10.1099/mic.0.000764. Hassan, E.M. et al. (2020) ‘A review of cryptosporidium spp. and their detection in water’, Water Science and Technology , 83(1), pp. 1–25. doi:10.2166/wst.2020.515. News, S. (2024) ‘Brixham: More than 50 people in Devon ill from contaminated water - as South West Water’s owner posts £166m profit’, Sky News , 21 May. Available at: https://news.sky.com/story/brixham-more-than-50-people-in-devon-ill-from-contaminated-water-as-south-west-waters-owner-posts-166m-profit-13140820#:~:text=More%20than%2050%20cases%20of,water%2C%20health%20bosses%20have%20said . Sparks, H. et al. (2015) ‘Treatment of cryptosporidium: What we know, gaps, and the way forward’, Current Tropical Medicine Reports , 2(3), pp. 181–187. doi:10.1007/s40475-015-0056-9. Caccio SM. Cryptosporidium : parasite and disease, Immunology of Cryptosporidiosis. Springer Verlag Gmbh; 2016. Project Gallery

Natural substances and their treatment potential Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Using Natural Substances to Tackle Infectious Diseases 05/04/26, 14:43 Last updated: Published: 06/06/23, 17:06 Natural substances and their treatment potential Introduction There is increased concern of antimicrobial resistance, especially when referring to bacteria with superbugs such as Methicillin-resistant Staphylococcus aureus (MRSA) and Carbapenem-resistant Enterobacteriaceae (CRE) as they impact lives globally, mainly through fatalities. Given this predicament, It seems that humanity is losing as a result of this pressing issue. However, it is possible for healthcare professionals to utilise more natural products, which are chemicals made by plants, animals and even microorganisms. This includes resources such as wood and cotton aside from food like milk and cacao. In the context of medicinal treatments, an important justification for using more natural products is because although synthetic or partially synthetic drugs are effective for treating countless diseases, an article found that 8% of hospital admissions in the United States and approximately 100,000 fatalities per year were due to people experiencing unfortunate side effects from these drugs. This article explores three specific natural products, where each have similar and unique health properties that can be harnessed to tackle infectious diseases and its subsequent consequences when left sufficiently unaddressed (i.e. antimicrobial resistance). Honey One of the most famous natural products that has been referenced in various areas of research and has been a food and remedial source for thousands of years is honey. It has properties ranging from antibacterial to antioxidant, suggesting that when honey is applied clinically, it has the potential to stop pathogenic bacteria. For example, honey can protect the gastrointestinal system against Helicobacter pylori , which causes stomach ulcers. In disc diffusion assays, the inhibitive properties of honey were shown when honey samples were evaluated holistically as opposed to its individual ingredients. This implies that the macromolecules in honey (carbohydrates, proteins and lipids) work in unison with other biomolecules, illustrating that honey is a distinctive remedy for preventing bacterial growth. For tackling infectious diseases, particularly against wound infections among others, honey’s medicinal properties provide a lot of applications and because it is a natural product, honey would not present any drastic side effects to a patient upon its administration. Garlic Another natural product that can be effective against microorganisms is garlic because similar to honey, it has antimicrobial and antioxidative compounds. A study judged different garlic phenotypes originating from Greece and discovered that they were beneficial against Proteus mirabilis and Escherichia coli aside from inhibiting Candida albicans and C. kruzei . As for fresh garlic juice (FGJ), it increases the zone of inhibition in various pathogens at 10% and more along with it displaying minimum inhibitory concentrations (MICs) in the 4-16% range. Therefore, garlic in solid or liquid form does show potential as a natural antimicrobial agent, especially against pathogenic bacteria and fungi. With this in mind, it too has multiple applications like honey and should be further studied to best isolate the chemical compounds that could be involved in fighting infectious diseases. Turmeric Curcuma longa (also known as turmeric) is one other natural product with unique properties like garlic and honey, making it a suitable candidate against various microbes. One specific pigment that is part of the ginger family and found in turmeric is curcumin, which can tackle diverse microbes through numerous mechanisms illustrated below in Figure 2 . With this said, curcumin has drawbacks: it is highly hydrophobic, has low bioavailability and quickly breaks down. Although when paired with nanotechnology for delivery into the human body, its clinical applications can be advantageous and an additional observation about curcumin is that it can work collaboratively with other plant derived chemicals to stop antibiotic resistant bacteria. One specific bacterial strain that turmeric can attack is Clostridium difficile, a superbug that causes diarrhoea. A study had 27 strains to measure the MICs of turmeric constituents, particularly curcuminoids and curcumin. The results showed reduced C. difficile growth in the concentration range 4-32 μg/mL. Moreover, they had no negative impacts on the gut microbiome and curcumin had more efficacy in stopping C. difficile toxin production compared to fidaxomicin. Thus, turmeric is efficacious as a natural antimicrobial chemical and with further experimentation (same as honey and garlic), it can be harnessed to prevent infectious diseases besides their impact on human lives. Conclusion Considering the above examples of natural products in this article and others not mentioned, it is clear that they can be powerful in the battle against infectious diseases and the problems associated with them, mainly antimicrobial resistance. They are readily available to purchase in markets and shops at low cost, making them convenient. Moreover, populations in Eastern countries like China and India traditionally have used, and are still using these materials for curing pain and illness. In turn, manufacturing medicines from natural products on a larger scale has the prospect of preventing infectious diseases and even alleviating those that patients currently have. Written by Sam Jarada Related article: Mechanisms of pathogen evasion Project Gallery

Properties of space Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Topology in action 17/02/25, 14:51 Last updated: Published: 29/09/23, 20:09 Properties of space Let’s say I put a sphere in front of you. I’m sure you could go through and tell me the basic facts and formulas surrounding it, many if which containing Pi. And even better, if you were a bit more fluent in maths, you could go further and start telling me about the geometry of the shape, say how the gradient had to disappear at a certain point or an assortment of many other things. But if we dive a little deeper into pure maths, it starts getting a little more complicated. When labels like Hausdorff get casually thrown about (meaning you can always separate two distinct points with an open boundary, which you certainly can do on a sphere!) it can really build up and become quite hard, especially if someone then puts in front of you two spheres stuck together. This is where the study of topology comes in and starts helping out, allowing us to start to categorise certain spaces without having to worry about all the small details that could catch you out. Topology is certainly found in the purer side of maths, generally seen as one of the more abstract modules to be taking at undergraduate level (as seen by the exam scores). But thinking of it just as some far away concept disconnected with the rest of the world would be foolish. Thinking back to what I said before about gradient fields on a sphere, this is more commonly known in maths as the “Hairy Ball Theorem” named as such as if you had a ball of hair, you wouldn’t be able to smooth it all out without a cow’s lick. And in mathematical terms it means that a continuous vector field has to disappear at a certain point. And maybe not readily apparent but this comes up in loads of places, the most obvious of which is that two points on the Earth will always have the exact temperature! But moving to Biology we see a lot more applications, even as early as in A-level study. Just thinking about how a protein will fold is all to do with the topological properties of them. DNA is a bit more complex understandably, with more base pairs it becomes incredibly flexible, able to bend into many shapes, but like topological spaces this flexible has limits. It doesn’t pass through itself nor tear, so it allows us to start applying our theorems to it. A key one of these is Knot theory, which of course is the study of knots. Knots in maths are defined as having no open ends and being complex, which helpfully is exactly like DNA! As you hopefully know, its coiled form has no open ends, and in order to untangle it we have to go through the process of cutting at double points. The amount of times this is needed to untangle is called the 'unknotting number' in topology and this mathematical modelling of the process allows biologists to move away from the microscope and still get a more accurate look on what’s happening. Written by Tom Murphy Related article: Quantum chemistry Project Gallery

(LINNAEUS, 1758) Killer Whale Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Orcinus orca 25/03/26, 16:41 Last updated: Published: 06/06/23, 15:19 (LINNAEUS, 1758) Killer Whale DEFINITION & DIAGNOSIS Orcinus orca comes from the Delphinadae family (oceanic dolphins) and are the largest members of the dolphin family. The largest male orcas can grow up to 10 metres while for females, upto 8.5 metres. They have proportionately bigger dorsal fins that other big delphinids ranging between 1/10 th to 1/5 th of their body length. Orcinus orca can be easily identified by their colouration- black and white. It has also been seen that their skull is larger and holds the largest brain compared to all the other dolphins except Pseudorca crassidens (false killer whale). TAXONOMIC HISTORY Species: Orcinus orca Genus Orcinus, Family Delphinidae, Class Mammalia, Phylum Chordata, Kingdom Animalia . Synonyms : Orca ater, Orca capensis, Orcinus glacialis, Delphius gladiator, Orcinus Nannus, Orca recipinna, Delphinus orca FEATURES Killer whales are predominantly black with a white midsection mammals with a blunt head that has no distinct beak. Females usually grow to be 7m and males 8.2m. They also have large flippers which, in adult males, can measure up to 20% of their body length but in females and young males they will only achieve up to 11-13% of their body length. They also have a dorsal fin which in males can reach up to 1.8 m in length but in females it only reaches 0.9m. This difference in dorsal fin length can be useful in determining the sex of O.orca . The white midsection runs across the whole lower jaw but tightens between the flippers. This white area can be seen as more yellowish incertain oceans, mainly in the Antarctic, and more predominantly in adolescents. ANATOMY AND PHYSIOLOGY A killer whale’s skin is very smooth and the outer layer continuously sheds and behind the dorsal fin and back, there is a grey- white patch known as a ‘saddle patch’ (Figure.1). O.Orca have dorsal fins and have paddle shaped pectoral fins which help control directional movement. The skeleton of a killer whale is robust and long and has a skull, backbone and a bone structure of the pectoral flippers. In general it was seen that O.Orca’s facial anatomy was slightly different to a typical delphinid structure of an asymmetrical nasal sac but some structures were smaller compared to several other species. Their teeth are conical shaped and curved inward and backward (Figure 2). The temporal fossa is very large, showing that there is a strong temporal muscle helping with closure of the jaw. Meuth examined that the amino acid sequence of myoglobin of O.Orca had similarities to Globicephala than to other delphinids and phocoenids with myoglobin. The reniculi of the kidney of the killer whale was found to be in groups of four which are connected. Differences have been seen with Hyperoodon based on the venous return in the kidney and the O.Orca have no peripheral venous complex whilst Hyperoodon does. REPRODUCTIVE BEHAVIOUR The breeding cycles range over many months and vary depending on where the species are found. For example, in the northeast Atlantic, mating takes place between late autumn to midwinter. The approximate annual birth is between 4 to 5% and the annual pregnancy rates are roughly around 13.7 to 39.2%, and the growth spurt of an adolescent male killer whale varies within a range of 5.5 to 6.1 m, this is also the the time in which they reach sexual maturity. This was confirmed after comparing and examining two different male adolescents. The individual with 656-cm and testes masses of 3,632 g (R) and 2,270 g (L) was not sexually mature, but the individual that was 724-cm with 11,400 g (R) and 12,200 g (L) testes was sexually mature. A further examination of 57 mature males found in the Antarctic showed us that the average testis width is 22 cm and length is 55 cm. The average testis mass was calculated at 10,000 g with a maximum mass of 23,100 g. Prior to this peak, the growth curves of males are similar to that of females. The length for a female killer whale to become sexually mature ranges between 4.6 to 5.4 m. This length varies depending on whether the individual is found in the northeastern Atlantic or the Antarctic. If they are found in the Atlantic they become sexually mature around 4.6m and if they are found in the Antarctic they become sexually mature around 5.4m. The ovaries size range from 10 to 12 cm by 5 to 7 cm. The maximum size of foetuses varies geographically. The largest found in the North Pacific was 274cm, the one in North Atlantic is 255cm and 250 cm for the Antarctic. The smallest foetuses recorded are 228 cm for the North Pacific, 183cm for the North Atlantic, and 227 cm for the Southern Hemisphere . Calves are usually dependent for at least 2 years and weaning takes place when a calf grows to 4.3 m in length with lactation lasting for around 12 months . The sex ratios at birth on average looks like it is 1:1, however the ratio of males to females has been reported as 1.34:1 for the Marion Islands and 0.83:1 for the northeast Pacific. ECOLOGY O.orca are carnivores and also opportunistic feeders so their diets change seasonally and based on the region they’re in. They mainly consume fish but it has been found that they can also prey on seabirds and other marine mammals such as minke whale, squid and pinnipeds. The estimated daily food intake is thought to be around 4% of their body weight. Predation for killer whales can also determine their migration such as in the Atlantic it is dependent on the migration of herring. Although O.Orca predate on many different species’, the only predator for orcinus orca is humans. They are mainly hunted for oil and meat or killed as they are competition for fishermen. In Japan and Norway the fresh meat of killer whales is eaten and the old meat is usually used for fertilisers or for bait. To figure out the age of O.orca the teeth can be sectioned and the dentine or cementum layers can be counted but this can be hard to determine due to the presence of accessory layers as well. The estimated lifespan of killer whales is thought to be 25 years but could be as long as 35 to 40 years. Killer whales aren’t subject to many diseases but the main one they face is infection in the pulp cavity due to the wearing down of teeth. If the infection penetrates through the pulp cavity it can cause a jaw abscess. In captive killer whales the main killers are pneumonia, bacterial infections, systemic mycosis and mediastinal abscess. Written by Jeevana Thavarajah Related article: Why blue whales don't get cancer Project Gallery

Food deserts Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link How rising food prices contribute to malnutrition 05/06/26, 20:28 Last updated: Published: 18/08/23, 20:13 Food deserts Introduction Over the past year, there have been news articles explaining how food has become more expensive along with people choosing between heating their homes and paying for groceries. (According to the Office for National Statistics (ONS), the annual inflation rate for food and non-alcoholic beverages fell to 3.6% in the 12 months to January 2026, down from 4.5% in December 2025). There are various reasons for the food price increase; some of them include Brexit, lack of agricultural productivity and weakening of the British pound. Therefore, the spending habits of the general population have shifted towards ultra-processed foods (UPFs) as they tend to be cheaper compared to minimally processed food (MPFs). Yet, UPFs are really unhealthy with a cohort study discovering that there was an increase in mortality by 18% with each additional serving. For people living in food swamps and deserts, this is a harsh reality for them and there have to be policies to properly address this. The difference between food deserts and swamps Food deserts are places where populations have limited access to healthy and affordable food (i.e. MPFs); there are factors that contribute to this phenomenon such as having lower income or geographic location whereby there is a long distance to the nearest market. However, the increase in food prices as illustrated above can even be a part of the problem. In contrast, there are food swamps, which are areas containing more businesses that sell foods lacking nutritional value, so UPFs as opposed to MPFs. This also relates to the cost of groceries because certain populations living in food swamps are likely to purchase UPFs because they are in closer proximity than MPFs, besides being cheaper. Both situations can contribute not only to obesity, but other forms of malnutrition which will be explored below. Malnutrition To suffer from malnutrition means that there is an imbalance of nutrients and can be categorised based on undernutrition or overnutrition along with disparity in macronutrients (carbohydrates, fats and proteins) and micronutrients (vitamins and minerals). Additionally, there are countries experiencing specific forms of malnutrition such as undernutrition in comparison to others due to ongoing warfare, lack of nutritional education and/or living in poverty. The impact of malnutrition on organs in Figure 1 happens because there is deficiency in certain macronutrients and/or micronutrients, which are essential in the structure and functioning of the body. Another consequence of malnutrition is weight loss because there is depletion of fat and muscle mass in the body, leading to impaired muscle function. Food deserts/ swamps and malnutrition Going back to food deserts/swamps, their impact on malnutrition can be drastic. For example, a review focusing on food insecurity (disrupted food intake/eating patterns due to low income or supplementary resources), suggested a link between malnutrition and food insecurity along with a possible association between malnutrition and gut microbiome being negatively altered, though more research is needed. Another review looking at food insecurity in both US adults and children discovered that in a food-insecure adult’s diet, they had less vegetables, fruits and dairy leading to reduced vitamins A and B6, calcium, magnesium and zinc. How do both reviews relate to food swamps/deserts? Well, populations who are food-insecure may be likely to live in areas where there is a lack of access to healthy foods (i.e. food swamps/ deserts). Conclusion Taking into account everything discussed in this article, it seems that governments in countries where food swamps/deserts are prevalent need to address this issue through effective policies. Otherwise, there could be a future where there is an increase in chronic diseases like malnutrition. There is even potential susceptibility to infectious diseases due to malfunctioning organs stemming from malnutrition. Written by Sam Jarada Related articles: Food at the molecular level / Famine-induced epigenetic changes / Junk food advertising Project Gallery

And its chemical effects Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Exposing medication to extreme heat 09/07/25, 14:09 Last updated: Published: 08/10/23, 16:18 And its chemical effects Introduction The majority of us look forward to when summer is just around the corner. It is a time for parents to start planning days off to be able to go on holiday with their kids to relax from their studies and enjoy sunsets at the beach. But for people who take medication, whether this just be a week-long course of antibiotics or for long-term conditions, summer may also be a chance for some negligence to occur. Specifically, alongside making sure you have applied SPF to protect your skin from the sun’s rays, you should also protect your medicine as well. This applies to both oral and non-oral drugs. Experts at The Montreal Children’s Hospital say that “many prescription drugs are very sensitive to changes in temperature and humidity”; in this article, we will therefore discuss the effect of extreme heat on drugs from a medicinal chemistry perspective. Factors affecting drug activity due to heat Certain drugs may begin to degrade before their expiry date if not stored appropriately. This affects the efficacy, which is the maximum biological response that is achievable with a certain drug. A dose-response curve can be plotted (see Figure 1 ) to show the relationship between the two variables; the label Emax refers to the efficacy. During hot weather, the structure of the drug can change and therefore unable to bind to its target, causing a lowered and shifted Emax to be seen. Simply put, the medication will not relieve your symptoms as effectively. Another physiochemical property of a drug that can be altered in the heat is the potency. Many people confuse this term with efficacy, but potency refers to the concentration of a drug required to achieve 50% of its maximum therapeutic effect i.e., half the Emax. Potency is therefore also known as EC50, which abbreviates for ‘half maximal effective concentration’. The lower the concentration needed, the more potent your drug is. Like reduced efficacy, the drug’s potency will also decrease in the heat due to altered chemical structure. For drugs like antibiotics, it is crucial to note that if potency is reduced significantly, it could risk infection spreading to other parts of the body as the medication will not fight off bacteria as well as it should. Potentially dangerous! Finally, drug absorption is when a drug moves into the bloodstream after being administered. The chemical structure of the drug and the environment in which it is present hugely affects this; for example, if a lipophilic (‘fat loving’) drug is also present in a lipophilic surrounding, fast absorption is seen as they work well with each other. As you have probably guessed, high temperatures outside of the body can reduce drug absorption due to the above factors mentioned, as the drug is not in its optimal structure to be absorbed effectively. Examples of medicine that are heat sensitive Here is a list of some medicines that require extra care to prevent the above: 1) Nitroglycerin – used to treat chest pains for those with cardiovascular disease. It is especially sensitive to heat or light as it degrades very fast. Dr. Sarah Westberg, a professor at The University of Minnesota College of Pharmacy, says you should follow the storage instructions and replace them regularly. 2) Some antibiotics – research has shown that ampicillin, erythromycin, and furosemide show a reduction in activity in the heat, although this was found after storing them for a year in a car with a temperature exceeding 25 degrees Celsius. Other antibiotics such as cefoxitin are shown to have some “stability in warmer climates”. 3) Levothyroxine – used to treat an underactive thyroid, also known as hypothyroidism. This drug should be stored between 15 to 30 degrees Celsius, although even 30 is quite high so the lower the temperature the better. Interestingly, levothyroxine isn’t heat sensitive itself, it is the fact that the body becomes sensitive to the drug and may make a person feel strange in the heat. 4) Metoprolol succinate – used to treat high blood pressure, also known as hypertension, and heart failure in emergencies . The ideal storage conditions for this drug are 15 to 30 degrees Celsius, like Levothyroxine. Key things to look out for with your medicine in the heat Below are the 2 main things you should be checking for before taking your medicine in the summer: 1) Change in colour – Light can initiate all sorts of reactions, such as oxidation. If, for example, your medicine that is normally white has now changed into a different colour, this suggests that a reaction has taken place within your drug and will not be effective when administered. 2) Change in texture – Similar to change in colour, if a normally solid, oral tablet has become soft then this also suggests that the medication will not be as effective when consumed. How you can prevent your medicine from degrading To make sure you do not contribute to wasting medicine, you should do the following: 1) Check storage information – for any medication that you take, this will let you know how to store them correctly. 2) Travel with care – do not pack prescription drugs into your luggage, as it will almost always become very warm due to the surrounding environment. Instead, carry your medicine with you with the labels still on. 3) Do not leave medicine in any vehicle – everyday vehicles such as cars tend to get warm after a period , which can affect the colour and texture of your medicine. 4) Careful deliveries – for those who have their medicine delivered to them, you can request for your local pharmacy to deliver your medicine in temperature-controlled packages. Summary As discussed, chemicals in the majority of over-the-counter prescription drugs are heat sensitive and should therefore be handled with care, to prevent degradation of the drug. Changes in colour and texture are signs of degradation, which result in loss of efficacy, absorption, and potency. However, many other pharmacological factors interfere, so scientists especially involved in drug synthesis should (or continue to) take great precautions with the manufacturing process. Drugs are costly to make and require a lot of time, so the takeaway is to store them correctly! You should contact your pharmacist if you are still unsure about your prescription(s). Written by Harsimran Kaur Sarai Project Gallery

Antimicrobial Resistance (AMR) is a growing concern for healthcare systems globally Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Are we doing enough to fight anti-fungal resistance? 26/04/26, 14:30 Last updated: Published: 04/11/24, 15:29 Antimicrobial Resistance (AMR) is a growing concern for healthcare systems globally Introduction to fungi Fungi are a fascinating yet relatively untouched area of microbiology. From growing in damp forest soil to the human body, these eukaryotes (surprisingly more closely related to animals than plants!) reproduce sexually and asexually, producing hyphae (long, branching filaments) to absorb nutrients. Even in the human body, fungal infections can range from athletes' foot to severe cases of invasive pneumonia. Despite its diverse and incredibly interesting nature, only 5% of all estimated fungal species worldwide have been discovered. There is a significant lack of knowledge regarding these amazing microorganisms. The challenge of antimicrobial resistance Antimicrobial Resistance (AMR) is a growing concern for healthcare systems globally. AMR is the process by which microbes develop decreased sensitivity to antimicrobial drugs, meaning they can evade drug and immune response, creating the potential for superbugs (i.e. Multi-Drug Resistant Staphylococcus Aureus/MRSA). An increasing number of resistant fungal species are emerging, with more than 90% of Candida Auris strains in the US now fluconazole resistant. Microorganisms can confer resistance in various ways, such as the misuse of antimicrobial drugs and pesticides in healthcare and agriculture or random genetic evolution (secondary vs primary resistance). Biofilm formation can also contribute to this, particularly for those with inserted medical devices. This can be seen in Candidiasis, for example on inserted catheters, as can be seen in Figure 2 . AMR was thought to be responsible for 1.27 million deaths globally in 2019, with an 8% increase in resistant infections in the UK from 2021-22. Global efforts regarding resistance appear to focus on antibiotic resistance, much reflective of worldwide research efforts. This leaves us wondering, are we doing enough to fight antifungal resistance? Mechanisms of fungal resistance Fungal infections, although typically mild, often present most severely in the immunocompromised, particularly those with cancer or who have had recent organ transplants. Invasive infections are cleared using five classes of antifungal drugs: azoles, polyenes, allylamines, flucytosine, and echinocandins, the two most common being azoles and echinocandins. Azoles aim to inhibit ergosterol synthesis, which is crucial for cell membrane stability, whilst echinocandins interfere with beta-1,3-D-glucan synthesis (a major component of fungal cell walls). Fungi can come in two forms: mould fungi (multicellular units containing branching hyphae), and yeast fungi (unicellular with the ability to ferment carbohydrates). In yeasts, azoles target the Erg11 protein (or Cyp51A for mould fungi), which disrupts ergosterol synthesis and causes the build up of 14a-methyl sterols. In turn, this disrupts membrane activity. Azole resistance can develop through different pathways: changes in the Erg11 amino acid structure, changes in Erg11 expression, and alterations to drug efflux pathways. For Candida species, amino acid substitutions occurring at the Erg11 enzyme binding site often lead to azole resistance, whilst in Aspergillus fumigatus, changes occur at codons 54-220 in Cyp51A. Resistant Candida albicans can also overexpress Erg11, meaning a higher drug concentration is needed to combat infection. Some fungal species, such as Candida spp. confer azole resistance by utilising drug efflux systems, particularly the ABC transporter MDR1, where a gain of function mutation can lead to multidrug resistance. Loss of heterozygosity, for example, by aneuploidy, can lead to resistance if this occurs across Erg11 or MDR1 gene loci. Inhibition of the Hsp90 pathway (a component of the cellular stress response) can alleviate both azole and echinocandin resistance and regulate biofilm resistance. Hsp90 stabilises the terminal MAPK component, increasing cell wall integrity (most antifungal drugs target the fungal cell wall). Global nature of AMR Global schemes have emerged to combat AMR, with fungal efforts appearing to lag behind its bacterial equivalent; The WHO published its first priority bacterial pathogens list in 2017, which has been effectively used by pharmaceutical companies, researchers, and local health trusts to target bacterial species, asserting themselves as an increasing risk. WHO Fungal Priority lists didn’t emerge until 2022, which was the first global effort to establish fungal species of risk. The One Health approach, another global strategy, aims to combat AMR by emphasising collaboration between multiple sectors, increasing innovation and creating clear communication. Its main aims lay in identifying knowledge gaps, involving policymakers, creating networks and sharing data. In addition to global strategies, national ones exist. The UK government made its own five year AMR-combatting plan, implementing a One Health approach; Previous plans have proven successful; antimicrobial exposure was reduced by 8%, with a further 81% reduction in antibiotic sales for food-producing mammals. It is clear AMR (particularly fungal resistance) is becoming an increasingly worrying issue. In 2019, UK deaths directly arising from drug resistant infections nearly matched those from stomach cancer, with an estimated further 35,000 deaths indirectly resulting from resistant infections. Hence, measures must be in place to contain its potential for worldwide damage. Insufficient action against AMR was predicted to have long-lasting effects like the COVID-19 pandemic every five years. Since drug-resistant fungi have the potential to cause significant burden on healthcare systems globally, what is currently being done to combat Fungal AMR? What more can we do? Fungal infections are the fifth leading cause of death worldwide, yet less than 1.5% of infectious disease funding goes towards research of fungal infections. This could be because fungal infections present mildly in most healthy people. However, we cannot ignore the fatal consequences for those with pre-existing illnesses or the devastating effects that could ensue if we do not make significant efforts to eliminate fungal resistance. In its most recent five-year plan, the UK government stated its support for initiatives to increase agrochemical stewardship, particularly focussing on fungicides. The efforts outlined include establishing a pharmaceutical monitoring programme, funding research into AMR-driving chemicals, and a pilot AMR surveillance scheme. This is significant progress, however, it focuses on environmental fungal resistance, with a tendency to ignore research efforts and failing to actively address fungi in most sections. In April 2026, £4.5 million was awarded to an international collaboration including the University of Edinburgh, to help improve understanding of fungal diseases. This is a significant contribution, and can accelerate endeavours in research. To move forward, more efforts are needed to drive antifungal research - whether in expanding the number of antifungal classes available to patients or improving existing antifungal therapies (e.g. improvements in pharmacokinetics and efficacy). This is evidenced by the sheer number of antibiotics and respective classes compared to fungal counterparts; bacterial infections can be treated with a whopping two-fold more drug classes than their fungal equivalent. Moreover, the One Health approach emphasises the importance of diagnostics and testing; whilst most modern fungal testing methods are very sensitive and specific, some tests can only report positive results very late into disease progression (read more about One Health ). Hence, fungal diagnostic and testing approaches need to be optimised. This all can be achieved by pushing more funding towards fungal research and development, encouraged with government spending, and an emphasis on collaboration between academia and industry. How can we relay the importance of stewardship in agriculture, or bring more treatments to the bedside without collaboration and education? Written by Eloise Nelson Related article: The increasing threat of anti-microbial resistance REFERENCES Gaya E., Fungarium: Welcome to the Museum, 2019. Kundu R, Srinivasan R. Cytopathology of Fungal Infections. Current Fungal Infection Reports. 2021;15(3):81-92. The Role of Plant Agricultural Practices on Development of Antimicrobial Resistant Fungi Affecting Human Health: Proceedings of a Workshop Series.: Hearing before the National academies of Sciences, Engineering and Medicine (05.04.2023, 2023). Government U. Confronting antimicrobial resistance 2024 to 2029. In: Care DoHaS, editor. 2024. Fisher CM, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell ME, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nature Reviews Microbiology. 2022;20(9):557-71. Cowen EL, Sanglard D, Howard JS, Rogers DP, Perlin SD. Mechanisms of Antifungal Drug Resistance. Cold Spring Harbor Perspectives in Medicine. 2015;5(7):a019752. Fisher CM, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell ME, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nature Reviews Microbiology. 2022;20(9):557-71. WHO fungal priority pathogens list to guide research, development and public health action. WHO; 2022. Greener M. Why have we neglected fungal infections? Prescriber. 2022;33(8-9):20-3. Baker J, Denning WD. The SSS revolution in fungal diagnostics: speed, simplicity and sensitivity. British Medical Bulletin. 2023;147(1):62-78. Project Gallery